 | Up a level |
Gruenwald, Viktor, Ivanyi, Philipp 
ORCID: 0000-0002-2862-7302, Hermes, Barbara, Tuchscherer, Armin, Pink, Daniel, Bauer, Sebastian ORCID: 0000-0001-5949-8120, Lindner, Lars, Augustin, Marinela, Blocks, Andreas, Richter, Stephan, Reichardt, Peter, Crysandt, Martina, Hipper, Annette and Fischer, Marc
(2020).
A Randomized Phase II Study of Durvalumab and Tremelimumab Compared to Doxorubicin in Patients with Advanced or Metastatic Soft Tissue Sarcoma (Medisarc, AIO-STS-0415).
Oncol. Res. Treat., 43.
S. 173 - 174.
BASEL:
KARGER.
ISSN 2296-5262
Pink, Daniel, Richter, Adrian, Andreou, Dimosthenis, Richter, Stephan, Florcken, Anne, Deinzer, Christoph, Kasper, Bernd, Egerer, Gerlinde, Ivanyi, Philipp ORCID: 0000-0002-2862-7302, Tuchscherer, Armin, Kessler, Torsten, Schuler, Markus, Schmidt, Christian, Bahr, Jeannette, Ittermann, Till and Reichardt, Peter
(2020).
Which patients with pre-treated locally advanced or metastatic sarcoma benefit most from trabectedin treatment: First results of a retrospective study of the German Interdisciplinary Sarcoma Group (GISG-14-ReTraSarc).
J. Clin. Oncol., 38 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Abbas, Mahmoud, Steffens, Sandra, Bellut, Maria, Becker, Jan U., Grosshennig, Anika, Eggers, Hendrik, Wegener, Gerd, Kuczyk, Markus A., Kreipe, Hans H., Gruenwald, Viktor, Schrader, Andres J. and Ivanyi, Philipp ORCID: 0000-0002-2862-7302
(2016).
Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
Med. Oncol., 33 (6).
TOTOWA:
HUMANA PRESS INC.
ISSN 1559-131X